185 related articles for article (PubMed ID: 36578232)
1. Liquid Metal as Bioinspired and Unusual Modulator in Bioorthogonal Catalysis for Tumor Inhibition Therapy.
Zhang L; Sang Y; Liu Z; Wang W; Liu Z; Deng Q; You Y; Ren J; Qu X
Angew Chem Int Ed Engl; 2023 Feb; 62(9):e202218159. PubMed ID: 36578232
[TBL] [Abstract][Full Text] [Related]
2. A DNA-Gated and Self-Protected Bioorthogonal Catalyst for Nanozyme-Assisted Safe Cancer Therapy.
Zhang Y; Zhang L; Wang W; Deng Q; Liu M; Zhu Z; Liu H; Ren J; Qu X
Angew Chem Int Ed Engl; 2023 Aug; 62(32):e202306395. PubMed ID: 37268594
[TBL] [Abstract][Full Text] [Related]
3. Progress in controllable bioorthogonal catalysis for prodrug activation.
Liu X; Huang T; Chen Z; Yang H
Chem Commun (Camb); 2023 Oct; 59(84):12548-12559. PubMed ID: 37791560
[TBL] [Abstract][Full Text] [Related]
4. Transition metal catalysts for the bioorthogonal synthesis of bioactive agents.
van de L'Isle MON; Ortega-Liebana MC; Unciti-Broceta A
Curr Opin Chem Biol; 2021 Apr; 61():32-42. PubMed ID: 33147552
[TBL] [Abstract][Full Text] [Related]
5. A narrative review: progress in transition metal-mediated bioorthogonal catalysis for the treatment of solid tumors.
Wan X; Zhang Y; Nie Y; Zhang K; Jin Z; Zhang Z; Gan L; Liu X; He J
Transl Cancer Res; 2023 Aug; 12(8):2181-2196. PubMed ID: 37701121
[TBL] [Abstract][Full Text] [Related]
6. Degradable ZnS-Supported Bioorthogonal Nanozymes with Enhanced Catalytic Activity for Intracellular Activation of Therapeutics.
Zhang X; Lin S; Huang R; Gupta A; Fedeli S; Cao-Milán R; Luther DC; Liu Y; Jiang M; Li G; Rondon B; Wei H; Rotello VM
J Am Chem Soc; 2022 Jul; 144(28):12893-12900. PubMed ID: 35786910
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Design of Gold Catalysts for Bioorthogonal Polyzymes.
Hirschbiegel CM; Fedeli S; Zhang X; Huang R; Park J; Xu Y; Rotello VM
Materials (Basel); 2022 Sep; 15(18):. PubMed ID: 36143797
[TBL] [Abstract][Full Text] [Related]
8. A Polyoxometalate-Based Pathologically Activated Assay for Efficient Bioorthogonal Catalytic Selective Therapy.
Zhao H; Zhao C; Liu Z; Yi J; Liu X; Ren J; Qu X
Angew Chem Int Ed Engl; 2023 Aug; 62(32):e202303989. PubMed ID: 37293817
[TBL] [Abstract][Full Text] [Related]
9. Supramolecular regulation of bioorthogonal catalysis in cells using nanoparticle-embedded transition metal catalysts.
Tonga GY; Jeong Y; Duncan B; Mizuhara T; Mout R; Das R; Kim ST; Yeh YC; Yan B; Hou S; Rotello VM
Nat Chem; 2015 Jul; 7(7):597-603. PubMed ID: 26100809
[TBL] [Abstract][Full Text] [Related]
10. In situ activation of therapeutics through bioorthogonal catalysis.
Wang W; Zhang X; Huang R; Hirschbiegel CM; Wang H; Ding Y; Rotello VM
Adv Drug Deliv Rev; 2021 Sep; 176():113893. PubMed ID: 34333074
[TBL] [Abstract][Full Text] [Related]
11. Rational Utilization of Black Phosphorus Nanosheets to Enhance Palladium-Mediated Bioorthogonal Catalytic Activity for Activation of Therapeutics.
Rong M; Liu J; Sun Z; Li T; Li Y; Jiang C; Lu L
Angew Chem Int Ed Engl; 2023 May; 62(19):e202216822. PubMed ID: 36917027
[TBL] [Abstract][Full Text] [Related]
12. Transition Metal Ru(II) Catalysts Immobilized Nanoreactors for Conditional Bioorthogonal Catalysis in Cells.
Gao Z; Li Y; Xing J; Lu Y; Shao Q; Hu J; Zhao S; He W; Sun B
ACS Appl Mater Interfaces; 2024 Apr; 16(13):15870-15878. PubMed ID: 38520329
[TBL] [Abstract][Full Text] [Related]
13. Designed heterogeneous palladium catalysts for reversible light-controlled bioorthogonal catalysis in living cells.
Wang F; Zhang Y; Du Z; Ren J; Qu X
Nat Commun; 2018 Mar; 9(1):1209. PubMed ID: 29572444
[TBL] [Abstract][Full Text] [Related]
14. Single-Atom Catalysts Mediated Bioorthogonal Modulation of N
Sun M; Liu X; Liu Z; Zhang W; Li G; Ren J; Qu X
J Am Chem Soc; 2024 Mar; 146(12):8216-8227. PubMed ID: 38486429
[TBL] [Abstract][Full Text] [Related]
15. Modular Fabrication of Bioorthogonal Nanozymes for Biomedical Applications.
Huang R; Hirschbiegel CM; Lehot V; Liu L; Cicek YA; Rotello VM
Adv Mater; 2024 Mar; 36(10):e2300943. PubMed ID: 37042795
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable nanoemulsion-based bioorthogonal nanocatalysts for intracellular generation of anticancer therapeutics.
Nabawy A; Gupta A; Jiang M; Hirschbiegel CM; Fedeli S; Chattopadhyay AN; Park J; Zhang X; Liu L; Rotello VM
Nanoscale; 2023 Aug; 15(33):13595-13602. PubMed ID: 37554065
[TBL] [Abstract][Full Text] [Related]
17. Bioorthogonal nanozymes: an emerging strategy for disease therapy.
Zhang Z; Fan K
Nanoscale; 2022 Dec; 15(1):41-62. PubMed ID: 36512377
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Efficiency of Pd(0)-Based Single Chain Polymeric Nanoparticles for
Deng L; Sathyan A; Adam C; Unciti-Broceta A; Sebastian V; Palmans ARA
Nano Lett; 2024 Feb; 24(7):2242-2249. PubMed ID: 38346395
[TBL] [Abstract][Full Text] [Related]
19. Nanomaterial-based bioorthogonal nanozymes for biological applications.
Fedeli S; Im J; Gopalakrishnan S; Elia JL; Gupta A; Kim D; Rotello VM
Chem Soc Rev; 2021 Dec; 50(24):13467-13480. PubMed ID: 34787131
[TBL] [Abstract][Full Text] [Related]
20. Bioorthogonal catalytic patch.
Chen Z; Li H; Bian Y; Wang Z; Chen G; Zhang X; Miao Y; Wen D; Wang J; Wan G; Zeng Y; Abdou P; Fang J; Li S; Sun CJ; Gu Z
Nat Nanotechnol; 2021 Aug; 16(8):933-941. PubMed ID: 33972760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
